Susquehanna International Group, LLP Abbott Laboratories Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Susquehanna International Group, LLP holds 501,886 shares of ABT stock, worth $62.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

501,886

Previous 495,972 1.19%

Holding current value

$62.8 Million

Previous $51.5 Million 11.03%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $591,813 - $698,620	5,914 Added 1.19%	501,886 $57.2 Million
Q2 2024 Aug 15, 2024	SELL	$100.73 - $112.44 $2.8 Million - $3.12 Million	-27,767 Reduced 5.3%	495,972 $51.5 Million
Q1 2024 May 07, 2024	SELL	$109.52 - $120.96 $1.75 Million - $1.93 Million	-15,959 Reduced 2.96%	523,739 $59.5 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $10 Million - $12.3 Million	-111,294 Reduced 17.1%	539,698 $59.4 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $34.9 Million - $41.9 Million	-365,601 Reduced 35.96%	650,992 $63 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $7.18 Million - $8 Million	71,236 Added 7.54%	1,016,593 $111 Million
Q1 2023 May 16, 2023	BUY	$96.86 - $114.01 $20.7 Million - $24.4 Million	213,676 Added 29.2%	945,357 $95.7 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $52.5 Million - $61.6 Million	552,787 Added 309.0%	731,681 $80.3 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $17.4 Million - $20.2 Million	-180,199 Reduced 50.18%	178,894 $17.3 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $21 Million - $25.4 Million	-205,563 Reduced 36.4%	359,093 $39 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $14.4 Million - $17.6 Million	126,235 Added 28.79%	564,656 $66.8 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $8.56 Million - $10.5 Million	74,117 Added 20.34%	438,421 $61.7 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $62.5 Million - $69.2 Million	-535,837 Reduced 59.53%	364,304 $43 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $52.7 Million - $62 Million	497,925 Added 123.8%	900,141 $104 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $10.8 Million - $12.7 Million	99,013 Added 32.66%	402,216 $48.2 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $17.8 Million - $19.4 Million	-169,779 Reduced 35.9%	303,203 $33.2 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $7.39 Million - $8.98 Million	80,646 Added 20.56%	472,982 $51.5 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $13 Million - $16.6 Million	-169,602 Reduced 30.18%	392,336 $35.9 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $2.39 Million - $3.5 Million	38,048 Added 7.26%	561,938 $44.3 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $40.3 Million - $44.9 Million	513,219 Added 4809.47%	523,890 $45.5 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $1.92 Million - $2.08 Million	-23,454 Reduced 68.73%	10,671 $893,000
Q2 2019 Aug 16, 2019	BUY	$72.88 - $85.0 $452,657 - $527,935	6,211 Added 22.25%	34,125 $2.87 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $29,516 - $34,425	405 Added 1.47%	27,914 $2.35 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $256,138 - $309,672	3,868 Added 16.36%	27,509 $2.2 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $56,130 - $61,951	975 Added 4.3%	23,641 $1.44 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $3.62 Million - $4.09 Million	-64,320 Reduced 73.94%	22,666 $1.36 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $12.2 Million - $13.1 Million	-227,549 Reduced 72.34%	86,986 $4.96 Million
Q3 2017 Nov 20, 2017	BUY	$48.06 - $53.64 $15.1 Million - $16.9 Million	314,535	314,535 $16.8 Million

Others Institutions Holding ABT

# of Institutions

3,204

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $219B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Abbott Laboratories Transaction History